Evotec SE ADR (EVO)

Evotec SE ADR (EVO) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $478M; returns 1 day -2.6%, 1 week +8.7%, 1 year -62.9%.

Evotec SE is a drug discovery and development company operating in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates through two segments: Shared R&D and Just – Evotec Biologics.

Groups EVO belongs to

• Drug Discovery
• Biotechnology
• Contract Development and Manufacturing Organizations (CDMO)
• Life Sciences
• Biologics
• Outsourcing
• Healthcare
• Life Sciences Tools & Services
• R&D

EVO financial model: income statement, cash flow and balance sheet